메뉴 건너뛰기
Oncologist
Volumn 5, Issue 4, 2000, Pages 274-279
Lung cancer highlights
Author keywords

Metastatic disease; Non small cell lung cancer; Small cell lung cancer; Treatment
Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; GEMCITABINE; IRINOTECAN; MONOCLONAL ANTIBODY; PACLITAXEL; TOPOTECAN; VASCULOTROPIN;
EID: 0033855788     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.2000-0274     Document Type: Review
Times cited : (9)
References (10)
  • 1
    • 0008324418 scopus 로고    scopus 로고
    • A Randomized Phase III Trial of Four Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer (NSCLC). [Abstract 2] 36th Annual Meeting of the American Society of Clinical Oncology, New Orleans, LA
    • (2000)
    • Schiller, J.1    Harrington, D.2    Sandler, A.3
  • 2
    • 0008284944 scopus 로고    scopus 로고
    • A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in Untreated Advanced NSCLC: A Southwest Oncology Group Trial. [Absract 1777] 35th Annual Meeting of the American Society of Clinical Oncology, Atlanta, GA
    • (1999)
    • Kelly, K.1    Crowley, J.2    Bunn, P.3
  • 4
    • 0033950286 scopus 로고    scopus 로고
    • Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an Eastern Cooperative Oncology Group trial
    • (2000) J Clin Oncol , vol.18 , pp. 623-631
    • Bonomi, P.1    Kim, K.2    Fairclough, D.3
  • 5
    • 0034069620 scopus 로고    scopus 로고
    • Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
    • (2000) J Clin Oncol , vol.18 , pp. 2095-2103
    • Shepherd, F.1    Dancey, J.2    Ramlau, R.3
  • 6
    • 0008334597 scopus 로고    scopus 로고
    • A Randomized Phase II Trial Comparing Rhumab VEGF (Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Cell Growth Factor) Plus Carboplatin/Paclitaxel (CP) to CP Alone in Patients with Stage IIIB/IV NSCLC. [Abstract 1896] 36th Annual Meeting of the American Society of Clinical Oncology, New Orleans, LA
    • (2000)
    • DeVore, R.1    Fehrenbacher, L.2    Herbst, R.3
  • 7
    • 0008358932 scopus 로고    scopus 로고
    • Randomized Phase III Study of Irinotecan (CPT-11) and Cisplatin Versus Etoposide and Cisplatin in Extensive-Disease Small-Cell Lung Cancer: Japan Clinical Oncology Group Study (JCOG9511). [Abstract 1887] 36th Annual Meeting of the American Society of Clinical Oncology, New Orleans, LA
    • (2000)
    • Noda, K.1    Nishiwaki, Y.2    Kawahara, M.3
  • 8
    • 0008337275 scopus 로고    scopus 로고
    • Topotecan (T) vs. Observation (OB) Following Cisplatin (P) Plus Etoposide (E) in Extensive Stage Small Cell Lung Cancer (ES SCLC) (E7593): a Phase III Trial of the Eastern Cooperative Oncology Group (ECOG). [Abstract 1886] 36th Annual Meeting of the American Society of Clinical Oncology, New Orleans, LA
    • (2000)
    • Johnson, D.1    Adak, S.2    Cella, D.3
  • 9
    • 0008323806 scopus 로고    scopus 로고
    • Paclitaxel (P) + Topotecan (T) + GCSF for Previously Untreated Extensive Small Cell Lung Cancer (E-SCLC): Preliminary Analysis of Cancer and Leukemia Group B (CALGB) 9430. [Abstract 1922] 36th Annual Meeting of the American Society of Clinical Oncology, New Orleans, LA
    • (2000)
    • Lynch, T.1    Herndon, J.2    Lyss, A.3
  • 10
    • 0008285354 scopus 로고    scopus 로고
    • Phase II Trial of Topotecan and Paclitaxel (TP) with G-CSF Support Alternating with Etoposide and Cisplatin (EC) in Previously Untreated Extensive Stage Small Cell Lung Cancer (ED-SCLC). [Abstract 1921] 36th Annual Meeting of the American Society of Clinical Oncology, New Orleans, LA
    • Jett, J.1    Hatfield, A.2    Bauman, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.